Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism].

Yao xue xue bao = Acta pharmaceutica Sinica·2009
Same author

Overexpression of Midkine promotes the viability of BA/F3 cells.

Biochemical and biophysical research communications·2009
Same author

Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation.

Brain research·2009
Same author

[Open-path online monitoring of ambient atmospheric CO2 based on laser absorption spectrum].

Guang pu xue yu guang pu fen xi = Guang pu·2009
Same author

[Effects of Sarcandra glabra extract on immune activity in restraint stress mice].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2009
Same author

No association between the promoter polymorphisms of PAI-1 gene and sporadic Alzheimer's disease in Chinese Han population.

Neuroscience letters·2009

Related Experiment Video

Updated: May 13, 2026

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

Proliferation rate of somatic cells affects reprogramming efficiency.

Yongyu Xu1, Xiaoyuan Wei1, Min Wang2

  • 1Laboratory of Receptor-based Bio-medicine, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092; National Center for Drug Screening, Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

The Journal of Biological Chemistry
|February 27, 2013
PubMed
Summary
This summary is machine-generated.

Removing c-Myc from the reprogramming factors (OSKM) significantly boosted induced pluripotent stem cell (iPSC) generation. Slowing somatic cell proliferation enhances iPSC induction efficiency, crucial for regenerative medicine and drug discovery.

More Related Videos

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
09:43

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

Published on: April 23, 2014

Related Experiment Videos

Last Updated: May 13, 2026

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
09:43

Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus

Published on: April 23, 2014

Area of Science:

  • Stem Cell Biology
  • Epigenetics
  • Developmental Biology

Background:

  • Induced pluripotent stem cells (iPSCs) offer promise for regenerative medicine and drug screening.
  • Current reprogramming methods using Oct-4, Sox-2, Klf-4, and c-Myc (OSKM) face limitations due to undefined mechanisms and low efficiency.
  • Optimizing reprogramming conditions is essential for broader iPSC applications.

Purpose of the Study:

  • To investigate the role of c-Myc in the OSKM reprogramming process.
  • To identify factors influencing the efficiency of induced pluripotent stem cell generation.
  • To develop improved strategies for generating iPSCs.

Main Methods:

  • Utilized the OSKM factor combination for reprogramming mouse embryonic fibroblasts.
  • Experimentally removed c-Myc from the OSKM cocktail to assess its impact.
  • Analyzed gene expression related to cell cycle control during reprogramming.
  • Applied small molecule inhibitors to modulate cell proliferation during early reprogramming stages.
  • Evaluated the pluripotency and developmental potential of generated iPSCs via tetraploid complementation.

Main Results:

  • Removing c-Myc from the OSKM combination substantially enhanced iPSC generation efficiency.
  • iPSCs generated without c-Myc exhibited robust pluripotency and could form full-term mice.
  • Forced c-Myc expression promoted early-stage fibroblast hyperproliferation, negatively correlating with reprogramming efficiency.
  • Inhibiting cell proliferation in early reprogramming stages improved OSKM-mediated iPSC generation.

Conclusions:

  • Somatic cell proliferation rate is a critical determinant of reprogramming efficiency.
  • Reducing proliferation of somatic cells during the initial reprogramming phase can improve iPSC induction.
  • The role of c-Myc in reprogramming is complex, with its proliferative effects potentially hindering pluripotency induction.